Results 201 to 210 of about 112,794 (257)

Anticoagulation optimization and clinical impact of post-transplant deep vein thrombosis: clinical impact and a VV-ECMO subgroup analysis. [PDF]

J Artif Organs
Kurihara C, Miyashita Y, Kaiho T, Yamanouchi D.   +3 more
europepmc   +1 more source

Inflammatory macrophages drive smooth muscle dedifferentiation via YAP signaling in murine deep vein thrombosis. [PDF]

Cell Commun Signal
Yang H, Zhou T, Kim J, Liu B.
europepmc   +1 more source

Thrombosis and Circulation: From Bench to Bedside

Thrombosis and Circulation Research, EarlyView.
Zhenguo Zhai
wiley   +1 more source

Prevalence and risk of deep vein thrombosis recurrence in Thai patients with iliac compression syndrome. [PDF]

Res Pract Thromb Haemost
Chonwarangkoon H, Bua-Ngam C, Rongthong S, Chantrathammachart P, Niparuck P, Puavilai T, Piyajaroenkij T, Angchaisuksiri P, Boonyawat K.   +8 more
europepmc   +1 more source

Midterm clinical outcomes of mechanical versus rheolytic thrombectomy for iliofemoral or iliocaval deep vein thrombosis. [PDF]

J Vasc Surg Venous Lymphat Disord
Forgo G, Cardi S, Fumagalli R, Sebastian T, Périard D, Barco S, Kucher N, Engelberger RP.   +7 more
europepmc   +1 more source

Deep Vein Thrombosis Prevention in Acute Ischemic Stroke Patients with Lower Limb Paralysis: A Narrative Review. [PDF]

J Clin Med
Peng J, Long S, Feng L.
europepmc   +1 more source

Navigating Perioperative Anticoagulation Challenges in a Cancer Patient With Deep Vein Thrombosis: A Case Report. [PDF]

Cureus
Binoy JG, George G, Parambeth D, Abdul Rahman F.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Deep vein thrombosis

Lancet, The, 2005
Deep vein thrombosis and its sequelae pulmonary embolism and post-thrombotic syndrome are some of the most common disorders. A thrombus either arises spontaneously or is caused by clinical conditions including surgery, trauma, or prolonged bed rest. In these instances, prophylaxis with low-dose anticoagulation is effective.
Paul Kyrle
exaly   +3 more sources

Deep vein thrombosis

Current Treatment Options in Cardiovascular Medicine, 1999
Initially, patients with deep vein thrombosis (DVT) should be treated with a 5- to 7-day course of heparin or low-molecular-weight heparin (LMWH). They can be administered LMWH as outpatients. Patients with extensive iliofemoral thrombosis, major pulmonary embolism, or concomitant medical illness, and those at high risk for bleeding, should be treated ...
, Al-Zahrani, , Bates, , Weitz
openaire   +5 more sources